Welcome to our dedicated page for Nature's Miracle Holding SEC filings (Ticker: NMHI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Nature's Miracle Holding's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Nature's Miracle Holding's regulatory disclosures and financial reporting.
Nature’s Miracle Holding Inc. (NMHI) reported that shareholders holding approximately 98.6% of voting power approved by written consent two actions: authorizing the Board to implement a reverse stock split at a ratio between 1:5 and 1:20, and amending the Certificate of Incorporation to increase authorized common shares from 100,000,000 to 1,000,000,000.
The reverse split, if effected after the required 20-day notice period, would reduce outstanding shares proportionally; for example, at 1:10, outstanding common would move from 13,955,251 to 1,395,525 shares. Fractional shares will be rounded down to the next whole share. The Board may choose any whole-number ratio within the approved range or abandon the split at its discretion.
The company states the primary purposes are to support potential exchange listing requirements, broaden investor access, and provide flexibility for financings. The authorized share increase is intended in part to facilitate an equity line with GHS Investments for up to 55,817,669 shares under a $20,000,000 facility, as well as other potential corporate uses. No appraisal rights are available.
Nature’s Miracle Holding Inc. (NMHI) reported sharply weaker results for the quarter ended September 30, 2025. Revenue fell to $72,377 from $3.1 million a year earlier, as gross profit was essentially breakeven and operating expenses of $1.3 million drove an operating loss of $1.3 million. After $0.8 million of net other expense, mainly interest and financing costs, the company posted a quarterly net loss of $2.2 million, and a nine‑month net loss of $6.0 million.
Cash and cash equivalents were just $61,450 with a working capital deficit of about $19.0 million, total liabilities of $30.2 million, and a stockholders’ deficit of $8.9 million as of September 30, 2025. Management discloses that recurring losses, negative operating cash flow of $1.8 million for the nine months, and heavy debt raise “substantial doubt” about the company’s ability to continue as a going concern.
During the period the company used equity, preferred stock and convertible notes for financing and completed a $17.5 million related‑party acquisition of Zak Properties’ Ohio real estate, increasing property and equipment to $17.1 million from $4.2 million. NMHI also notes access to a $20 million equity line and several new funding agreements, but future financing remains uncertain.
Nature’s Miracle Holding Inc. (NMHI) entered financing and governance agreements. The company agreed to sell up to 2,000 shares of Series D Preferred Stock at $1,000 per share. An initial 500 shares closed for $500,000; a second 500-share closing for $500,000 is due before October 30, 2025, and a final 1,000-share closing for $1,000,000 is planned prior to an uplisting application. The Series D carries an 8% dividend and is convertible at $0.1180 per share, subject to a 4.99% beneficial ownership cap.
Separately, NMHI and GHS Investments LLC entered an agreement for 50 shares of Series A Preferred Stock in consideration of the investor’s consent to previously disclosed actions, including issuing 5,000 shares of Series B (with 20‑to‑1 super voting rights), 9,500 shares of Series C for an asset acquisition from CEO James Li, and a $3,000,000 promissory note to an affiliate of James Li. The Series A has a 12% dividend, a $1,200 stated value, and converts at $0.112 per share with a 4.99% cap. NMHI filed a Series D Certificate of Designations and related amendments, and increased designated Series B Preferred shares to 300. The securities were sold as unregistered under Section 4(a)(2) and/or Regulation D.
Nature's Miracle Holding Inc. filed an 8-K disclosing corporate actions dated September 18, 2025. The filing lists executed documents including a Membership Interest Purchase Agreement and a Promissory Note each dated September 18, 2025, plus a Certificate of Designation for Series B, an Amendment No. 1 to that certificate, and a Certificate of Designation for Series C. The filing identifies the company headquarters in Ontario, CA 91761 and is signed by Tie (James) Li, Chief Executive Officer. The document attaches an Inline XBRL cover page file. No financial amounts, purchaser/seller identities beyond the exhibit titles, or detailed transaction terms are provided in the disclosed text.